Country

Iraq

CAD4TB platform is being shown in Iraq

In 2023, Iraq reported

9,400 people

developed TB

720 people

losing their lives to the disease

2,455 individuals

remained undiagnosed or unreported

Our work in Iraq

Radiographers are setting up Delft Light systems in Iraq

2022

We delivered 16 CAD4TB to the International Organization for Migration (IOM). That same year, IOM, via PFSCM, received 4 Delft Light systems, each equipped with CAD4TB, as part of the Middle East Response (MER), a project funded by the Global Fund.

CAD4TB in Iraq

2024

1 CAD4TB was delivered to International Smart Medical Solution Co., Ltd. (ISMS).

CAD4TB platform is being shown in Iraq

2024

2 CompassDR systems, with 2 CAD4TB, were provided to IOM through PFSCM.

Press coverage

In 2025, The Global Fund and Arab News reported on Iraq’s progress in combating tuberculosis through innovative diagnostic solutions. The country has deployed mobile medical teams equipped with AI-powered CAD4TB and advanced diagnostic tools to reach displaced populations, prisons, and remote areas. These efforts have raised drug-resistant TB detection rates from 2% to 19% and reduced national TB prevalence from 45 to 15 cases per 100,000.

“CAD4TB is an efficient digital tool for TB diagnosis. It provides immediate results, enhancing patient care and saving lives,” said Dr. Bashar Hashim Abbas, National Tuberculosis Program, Mosul. Coupled with an all-oral regimen and integrated data systems, these innovations are restoring trust in healthcare and accelerating Iraq’s path toward the WHO End TB Strategy goals.

Connect with our representative in your country.

We work alongside Ministries of Health, implementing partners, and healthcare providers to ensure solutions are aligned with national strategies and local healthcare systems.

Mohammed Harbiye

Discover the in’s and out’s of our solutions in a private demo

During this conversation, you can
  • Review which solutions align with your programmatic and operational needs
  • Explore partnership opportunities and long-term collaboration
  • Address technical, clinical, and infrastructure considerations specific to your setting